➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Baxter
Express Scripts
AstraZeneca
Merck

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Litigation Details for CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2019)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-12-13 1 Complaint 2 of United States Patent Nos. 10,500,216 (“the ʼ216 patent” or “the patent-in-suit”), owned by Corcept… This complaint is an action for patent infringement under the patent laws of the United States, 35 U.S.C… of the ’216 patent, constitutes infringement of one or more of the claims of that patent under 35 U.…infringement of any claim of the patent-in-suit, until after the expiration of the patent-in-suit, or any later … COMPLAINT FOR PATENT v. External link to document
2020-02-20 26 Joint Discovery Plan States Patent No. 10,500,216 (“the ’216 patent”). Generally, the claims of the ’216 patent cover… Response: This is an action for patent infringement under the patent laws of the United States, 35 U.S.C…infringement of one or more claims of the ’216 patent, and that Teva’s ANDA Products will infringe those… after FDA approval. Teva asserts that the ’216 patent is invalid and/or not infringed. 2. Have …occurred in this litigation or relating to the ’216 patent. In Civil Action No. 18-3632, Teva produced a copy External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Medtronic
AstraZeneca
Merck
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.